Trinity Biotech plc (TRIB)
Nasdaq: TRIB · In Vitro & In Vivo Diagnostic Substances · filing with the SEC since 1996
Who owns Trinity Biotech plc
As filed with the SECHolders of 5% or more
3
MiCo IVD Holdings, LLC holds 17% of Class 'A' Ordinary Shares, as its SCHEDULE 13D/A filed Dec 10, 2025 says.
Directors and officers
5
report now, of 5 people on the record since 2026. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
MiCo IVD Holdings, LLC
SCHEDULE 13D/A · filed Dec 10, 2025 · Class 'A' Ordinary Shares · 17% in Dec 4, 2025
Perceptive Advisors LLC
SCHEDULE 13D/A · filed May 4, 2026 · Class A Ordinary Shares, $0.0001 par value per share · 9.9% in Jan 26, 2026
Novus Diagnostics Ltd.
SCHEDULE 13G · filed Mar 6, 2026 · @Class 'A' Ordinary Shares represented by American Depositary Shares
DAYLI Partners, Inc.
SCHEDULE 13D/A · filed Dec 15, 2025 · Class 'A' Ordinary Shares · reported falling below 5%
Mainstream Holdings, Ltd.
SCHEDULE 13D · filed Dec 26, 2024 · Class 'A' Ordinary Shares · reported falling below 5%
What TRIB reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Biosynth
An entity · subsidiary · owns, named in the 20-F filed Apr 30, 2026
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
No open-market trade is on the record for these years.
Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.